A five -year prostate cancer survival rate tells us the percentage of people with the same cancer stage that are alive five years after the diagnosis. A 10 -year survival rate tells us the percentage of people with the same stadium of cancer which are alive 10 years after the diagnosis.
Remember that each case is different and that the figures are only directives. It is important to know that these statistics did not consider the life expectancy of prostate cancer. In other words, they don’t tell you how long you will live, but they can give you an idea of how successful treatment could be based on the progression of cancer.
Overall, the rate of survival relating to five years for prostate cancer in the United States is close to 100%. But the survival rate for an individual diagnosed with prostate cancer will vary depending on the progression of cancer.
The American Cancer Society estimates survival rates at five years using the SEER database (SEER (Surveillance, Epidemiology and final results) of the National Cancer Institute in prostate cancer in three stages: locally, regional and distant, depending on the distance to which cancer has spread.
Located There is no sign that cancer has spread outside the prostate. The five -year survival rate is more than 99%.
Regional Cancer has spread to nearby lymph structures or lymph nodes. The five -year survival rate remains greater than 99%.
Far Cancer spread to certain parts of the body far from the prostate (lungs, liver, bone). The five -year survival rate is 37%.
Estimates only apply to cancer stage when diagnosed. These figures also do not say how long you can live with stadium prostate cancer, with or without treatment. Each case is unique, and life expectancy with prostate cancer is affected by many factors, such as age, overall health and the way the body reacts to treatment.
Above all, survival estimates are “upside down”, which means that they are based on the previous results of people with prostate cancer, and they may not be predictive for a person diagnosed today. This could be good news when you consider the rate of survival at five years for prostate cancer which has spread to parts far from the body.
According to William Dahut, MD, scientific director of the American Cancer Society, there are new therapies that could improve the survival of prostate cancer at this distant stage. “Over the past 10 or 15 years, we have developed better hormonal therapy, more powerful combined therapy for advanced diseases, hormonal hormone therapy based on mutations and immunotherapy for some patients who can prolong life,” he said.
:max_bytes(150000):strip_icc()/VWH-GettyImages-1468806253-671dd8cfafbf4ca1aec47abd2ce35b5e.jpg?w=390&resize=390,220&ssl=1 "Exhibition to glyphosate linked to higher tumors in rat")